LJH685
CAS No. 1627710-50-2
LJH685 ( LJH685 | NVP-LJH685 | NVP LJH685 )
产品货号. M17346 CAS No. 1627710-50-2
LJH685 是一种有效的 RSK1/2/3 泛 RSK 抑制剂 (IC50: 6/5/4 nM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥365 | 有现货 |
|
5MG | ¥656 | 有现货 |
|
10MG | ¥1191 | 有现货 |
|
25MG | ¥2398 | 有现货 |
|
50MG | ¥3815 | 有现货 |
|
100MG | ¥5573 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称LJH685
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述LJH685 是一种有效的 RSK1/2/3 泛 RSK 抑制剂 (IC50: 6/5/4 nM)。
-
产品描述LJH685 is an effective pan-RSK inhibitor for RSK1/2/3 (IC50: 6/5/4 nM).
-
体外实验LJH685 (0.01-100 μM; 72 hours) efficiently inhibits the growth of MDA-MB-231 and H358 cells in soft agar with EC50s of 0.73 and 0.79 μM, respectively.LJH685 (0.1-10 μM; 4 hours) efficiently reduces phosphorylation of YB1 at submicromolar concentrations and causes nearly complete inhibition at higher concentrations. Cell Proliferation Assay Cell Line:MDA-MB-231, H358 cells Concentration:0.01, 0.1, 1, 10, 100 μM Incubation Time:72 hours Result:The growth in soft agar was efficiently inhibited with EC50 values of 0.73 and 0.79 μM in MDA-MB-231 and H358, respectively.Western Blot Analysis Cell Line:MDA-MB-231, H358 cells Concentration:0.1, 0.3, 1, 3, 10 μM Incubation Time:4 hours Result:Efficiently reduced phosphorylation of YB1 at submicromolar concentrations and caused nearly complete inhibition at higher concentrations.
-
体内实验——
-
同义词LJH685 | NVP-LJH685 | NVP LJH685
-
通路Microbiology/Virology
-
靶点HCV
-
受体RSK1| RSK2| RSK3
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number1627710-50-2
-
分子量381.42
-
分子式C22H21F2N3O
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 31 mg/mL 81.28 mM
-
SMILESCN1CCN(CC1)c1ccc(cc1)c1ccncc1c1cc(F)c(O)c(F)c1
-
化学全称2,6-Difluoro-4-[4-[4-(4-methyl-1-piperazinyl)phenyl]-3-pyridinyl]-phenol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Aronchik I., et al. Mol Cancer Res. 2014 May;12(5):803-12.
产品手册
关联产品
-
SB-734117
SB-734117 抑制多种 HCMV 病毒株的高效复制。 SB-734117 表现出多种药理学,是 AGC 和 CMCG 激酶组中多种蛋白质的抑制剂。
-
Balapiravir
R1479 的前药,一种有效的、特异性的口服 HCV NS5B 聚合酶抑制剂。
-
Nucleoside-Analog-1
一种 4'-叠氮胞苷类似物,具有抗 HCV 活性。